← Back to catalogue

Allura 3D-CA

FDA UDI

Class II (US FDA UDI)

by Philips Medical Systems Nederland B.V.

Identity

Trade Name
Allura 3D-CA FDA UDI
Generic Name
Angiographic x-ray system application software FDA UDI
Device Name
Software medical device, used with a Philips Interventional X-Ray System. Creates a 3D model of the coronary vessel tree from a pair of 2D images from a rotational angiographic run. FDA UDI
Model / Reference
Allura 3D-CA - 3 FDA UDI
Description
Software medical device, used with a Philips Interventional X-Ray System. Creates a 3D model of the coronary vessel tree from a pair of 2D images from a rotational angiographic run. FDA UDI

Identifiers

Catalog Number
001009 FDA UDI
Primary DI / UDI-DI
00884838059245 FDA UDI
510(k) Number
K042334 FDA UDI
FDA Product Code
LLZ FDA UDI
IZI FDA UDI
GMDN Term
Angiographic x-ray system application software FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
892.2050 FDA UDI
892.1600 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Angiographic x-ray system application software

Allura 3D-CA by Philips Medical Systems Nederland B.V. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Angiographic x-ray system application software.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI d608ca57-210f-4e14-9a15-242abfd2f281 35 fields · synced Sep 18, 2026